JHS Svendgaard Laboratories Ltd

JHS Sven.Lab. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

JHS Svendgaard Laboratories Ltd

₹ 13.4 0.07%
12 Jun - close price
svendgaard.com BSE: 532771 NSE: JHS
About

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of
oral and dental products for national and international brands[1]

Key Points

Business Overview:[1]
JHSSLL manufactures Toothbrushes, Toothpastes, Mouthwash and Denture Tablets. Apart from working on its own brands viz. Dr. Gold, Aquawhite, etc. company also offers Contract Manufacturing Partnership to brands in domestic and international markets

Website BSE NSE - BE
  • Market Cap ₹ 115 Cr.
  • Current Price ₹ 13.4
  • High / Low ₹ 32.9 / 11.0
  • Stock P/E
  • Book Value ₹ 20.2
  • Dividend Yield 0.00 %
  • ROCE -5.11 %
  • ROE -10.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.66 times its book value
  • Company is expected to give good quarter
  • Debtor days have improved from 66.0 to 51.8 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -7.10% over past five years.
  • Promoter holding is low: 34.6%
  • Company has a low return on equity of -4.10% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.67%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
17.25 19.20 21.05 22.19 21.72 15.90 18.93 14.30 21.66 24.48 19.68 22.66 25.17
17.54 20.15 23.02 24.41 25.28 18.02 18.52 14.35 20.82 22.51 20.52 22.41 30.55
Operating Profit -0.29 -0.95 -1.97 -2.22 -3.56 -2.12 0.41 -0.05 0.84 1.97 -0.84 0.25 -5.38
OPM % -1.68% -4.95% -9.36% -10.00% -16.39% -13.33% 2.17% -0.35% 3.88% 8.05% -4.27% 1.10% -21.37%
2.01 1.19 2.52 0.94 -11.54 0.41 0.20 2.34 1.37 0.32 0.86 0.27 -1.44
Interest 0.14 0.12 0.12 0.16 0.11 0.13 0.10 0.11 0.13 0.12 0.11 0.13 0.21
Depreciation 1.44 1.41 1.49 1.46 1.61 1.32 1.50 1.63 1.90 1.97 1.98 1.97 2.02
Profit before tax 0.14 -1.29 -1.06 -2.90 -16.82 -3.16 -0.99 0.55 0.18 0.20 -2.07 -1.58 -9.05
Tax % 2,728.57% 157.36% -13.21% -4.83% -41.26% -18.35% -26.26% 98.18% 516.67% 415.00% 398.07% 15.82% -23.09%
-3.69 -3.32 -0.92 -2.76 -9.89 -2.59 -0.73 0.01 -0.75 -0.63 -10.32 -1.84 -6.96
EPS in Rs -0.57 -0.51 -0.14 -0.43 -1.52 -0.40 -0.09 0.00 -0.10 -0.08 -1.21 -0.21 -0.81
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
35 55 100 104 138 120 133 97 80 85 71 92
39 59 93 92 122 111 123 93 80 94 72 96
Operating Profit -4 -4 7 12 17 8 9 4 0 -9 -1 -4
OPM % -11% -7% 7% 11% 12% 7% 7% 4% 0% -11% -1% -4%
-3 -6 -17 0 32 5 1 6 8 -7 4 0
Interest 14 0 0 1 1 1 1 0 0 1 0 1
Depreciation 15 12 10 6 7 7 7 6 6 6 6 8
Profit before tax -35 -22 -22 5 41 5 2 3 2 -23 -3 -12
Tax % -18% 0% 0% -326% 32% 31% 1% 13% 228% -24% 18% 58%
-29 -22 -22 22 28 4 2 3 -2 -18 -4 -20
EPS in Rs -11.95 -9.19 -5.75 4.98 4.61 0.59 0.29 0.43 -0.38 -2.70 -0.52 -2.31
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: -7%
3 Years: 5%
TTM: 30%
Compounded Profit Growth
10 Years: -2%
5 Years: %
3 Years: %
TTM: -358%
Stock Price CAGR
10 Years: 5%
5 Years: -3%
3 Years: -15%
1 Year: -35%
Return on Equity
10 Years: 1%
5 Years: -2%
3 Years: -4%
Last Year: -11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 24 24 38 44 61 61 61 64 65 78 78 86
Reserves 21 78 63 91 116 119 121 127 125 96 92 88
54 19 2 2 2 7 3 2 2 3 5 6
74 33 19 19 26 33 46 21 19 39 22 22
Total Liabilities 173 153 123 156 205 220 230 215 211 215 197 202
121 108 65 65 71 69 58 59 55 65 90 90
CWIP 0 0 1 1 0 5 7 9 16 9 1 0
Investments 0 0 0 1 18 15 17 14 15 3 3 4
52 46 57 89 116 130 148 133 125 139 103 108
Total Assets 173 153 123 156 205 220 230 215 211 215 197 202

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
28 7 -6 -4 13 -10 15 15 -11 23 -9 -5
3 1 4 -3 -27 1 -7 -6 -1 10 -22 -20
-29 -10 4 10 14 4 -8 6 0 -1 2 23
Net Cash Flow 2 -1 2 3 0 -5 -0 16 -12 32 -28 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 60 82 25 48 113 171 262 221 74 80 66 52
Inventory Days 122 94 53 96 59 51 19 76 104 128 177 71
Days Payable 95 106 67 125 123 134 179 126 147 221 197 80
Cash Conversion Cycle 87 70 12 19 48 88 101 171 31 -13 46 42
Working Capital Days -548 -36 59 48 128 183 188 248 288 44 72 59
ROCE % -11% -14% -3% 5% 9% 4% 7% 2% 1% -2% -2% -5%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
42.23% 42.23% 42.23% 42.23% 42.23% 37.73% 37.73% 37.73% 37.73% 34.56% 34.56% 34.56%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.29% 0.15% 1.69% 1.59% 1.60%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.16% 6.21% 6.05% 0.00% 0.00% 0.00%
57.77% 57.77% 57.78% 57.78% 57.78% 62.25% 53.10% 53.75% 56.05% 63.76% 63.85% 63.84%
No. of Shareholders 24,31724,30524,30823,96523,80022,79422,64826,44825,76825,99426,27625,567

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls